F-Box Proteins and Cancer

Kanae Yumimoto1, Yuhei Yamauchi1, Keiichi I Nakayama1

  • 1Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan.

Cancers
|May 21, 2020
PubMed

Insights

F-box proteins are key to controlled protein degradation, impacting cell processes and cancer. Understanding their roles in targeting substrates is vital for cancer therapy development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Controlled protein degradation is crucial for cellular functions like division and differentiation.
  • Ubiquitin ligase-substrate interactions are fundamental to understanding cancer development and identifying therapeutic targets.
  • F-box proteins are integral components of SCF ubiquitin ligase complexes, acting as substrate recognition modules.

Purpose of the Study:

  • To summarize the diverse roles of F-box proteins in cancer, acting as either tumor promoters or suppressors.
  • To highlight proto-oncoproteins targeted by multiple F-box proteins.
  • To discuss the regulatory mechanisms of F-box proteins on their substrates in various cellular contexts.

Main Methods:

  • Literature review and synthesis of existing research on F-box proteins and their roles in cancer.
  • Analysis of studies identifying F-box protein interactions with substrates.
  • Examination of the functional outcomes of F-box protein-mediated protein degradation in cancer.

Main Results:

  • Specific F-box proteins have been identified as either promoting or suppressing tumor formation.
  • Certain proto-oncoproteins are ubiquitylated by multiple F-box proteins, indicating complex regulatory networks.
  • F-box proteins exhibit varied deployment strategies to regulate their target substrates in different cellular conditions.

Conclusions:

  • F-box proteins play significant and multifaceted roles in cancer biology.
  • Targeting F-box protein-substrate interactions presents a promising avenue for novel cancer therapeutics.
  • Further research into F-box protein regulation is essential for a comprehensive understanding of cancer mechanisms.

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K